|
| |
| | | 70236 | | 03.07.2026 | | iQone Healthcare Switzerland SA | | | | | | | 02.07.2031 | | | | | | | | | | 07.15. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Remsima 100 mg | solution à diluer pour perfusion | Infusionskonzentrat (Infliximab 100mg / 2.5ml) | L04AB02 | | | 02 | Remsima 350 mg | solution à diluer pour perfusion | Infusionskonzentrat (Infliximab 350mg / 8.75ml) | L04AB02 | |
|
|
|
